|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.62 USD | -2.11% |
|
+1.61% | +10.33% |
| 10/01 | Mizuho Adjusts Price Target on Centene to $47 From $40, Maintains Neutral Rating | MT |
| 08/01 | Cityblock Health and Meridian Health Plan of Illinois announce partnership | RE |
| Capitalization | 22.91B 19.7B 18.36B 17.09B 31.84B 2,067B 34.3B 211B 82.97B 988B 85.92B 84.15B 3,621B | P/E ratio 2025 * |
-4.62x | P/E ratio 2026 * | 23.8x |
|---|---|---|---|---|---|
| Enterprise value | 26.22B 22.54B 21.02B 19.56B 36.44B 2,366B 39.26B 242B 94.96B 1,131B 98.34B 96.32B 4,145B | EV / Sales 2025 * |
0.14x | EV / Sales 2026 * | 0.13x |
| Free-Float |
79.74% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Centene Corporation
| 1 day | -2.11% | ||
| 1 week | +1.61% | ||
| Current month | +10.33% | ||
| 1 month | +11.14% | ||
| 3 months | +24.86% | ||
| 6 months | +48.17% | ||
| Current year | +10.33% |
| 1 week | 44.79 | 47.47 | |
| 1 month | 38.02 | 47.47 | |
| Current year | 40.53 | 47.47 | |
| 1 year | 25.08 | 66.81 | |
| 3 years | 25.08 | 81.42 | |
| 5 years | 25.08 | 98.53 | |
| 10 years | 23.68 | 98.53 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah London
CEO | Chief Executive Officer | 45 | 22/03/2022 |
Drew Asher
DFI | Director of Finance/CFO | 57 | 07/05/2021 |
Susan Smith
COO | Chief Operating Officer | 50 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 67 | 31/03/2023 | |
Jessica Blume
BRD | Director/Board Member | 71 | 05/02/2018 |
H. Dallas
CHM | Chairman | 67 | 23/02/2022 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.11% | +1.61% | -28.73% | -41.93% | 22.91B | ||
| -1.78% | -1.15% | -37.52% | -31.79% | 312B | ||
| -0.75% | +1.55% | -6.90% | -22.62% | 82.86B | ||
| -1.95% | -3.65% | -3.13% | -11.80% | 74.51B | ||
| -1.02% | -0.84% | -4.83% | -44.67% | 33.3B | ||
| -0.46% | -1.53% | -38.87% | -39.83% | 9.33B | ||
| +0.31% | -0.86% | +54.22% | +80.89% | 4.16B | ||
| +4.33% | +5.76% | +38.89% | -14.72% | 2.33B | ||
| +0.96% | +1.16% | -29.57% | +111.29% | 1.34B | ||
| -1.12% | -7.65% | -27.05% | - | 356M | ||
| Average | -0.35% | +3.51% | -8.35% | -1.69% | 54.27B | |
| Weighted average by Cap. | -1.55% | +2.95% | -24.71% | -27.71% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 193B 166B 155B 144B 268B 17,403B 289B 1,777B 699B 8,320B 723B 708B 30,489B | 193B 166B 155B 144B 268B 17,429B 289B 1,780B 700B 8,333B 724B 710B 30,535B |
| Net income | -4.21B -3.62B -3.37B -3.14B -5.85B -380B -6.3B -38.76B -15.23B -181B -15.78B -15.45B -665B | 883M 759M 708M 659M 1.23B 79.66B 1.32B 8.13B 3.2B 38.08B 3.31B 3.24B 140B |
| Net Debt | 3.31B 2.85B 2.66B 2.47B 4.6B 299B 4.96B 30.52B 12B 143B 12.42B 12.17B 524B | 1.87B 1.61B 1.5B 1.39B 2.6B 169B 2.8B 17.21B 6.77B 80.6B 7.01B 6.86B 295B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/01/26 | 45.37 $ | -2.66% | 1,965,682 |
| 09/01/26 | 46.61 $ | -0.66% | 6,090,084 |
| 08/01/26 | 46.92 $ | +2.51% | 9,593,582 |
| 07/01/26 | 45.77 $ | +0.07% | 7,773,965 |
| 06/01/26 | 45.74 $ | +2.37% | 7,817,106 |
Delayed Quote Nyse, 13 January 2026 at 03:56 am AEDT
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CNC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















